More than 10% of fecal immunochemical tests (FIT) used for routine colorectal cancer (CRC) screening in a safety-net health system contained unsatisfactory samples that could not be processed, ...

A study of more than 21,000 average risk patients at 186 sites across the U.S., led by Regenstrief Institute and Indiana University School of Medicine research scientist Thomas Imperiale, M.D., has ...

FIT outperformed cfDNA in detecting advanced precancerous colorectal lesions, showing higher sensitivity and specificity. Blood-based tests offer easier implementation and potentially higher adherence ...

Noninvasive surveillance with multitarget stool DNA testing or fecal immunochemical testing (FIT) could potentially match colonoscopy for reducing long-term colorectal cancer (CRC) incidence and ...

Roughly 10% of fecal immunochemical tests (FIT) used for colorectal cancer (CRC) screening by a safety-net health system contained unsatisfactory samples that could not be processed. And fewer than ...

Q: My doctor always encourages me to do a colonoscopy for colorectal cancer screening. But I have friends who just do a stool test at home, which seems easier. Why should I go through the hassle of a ...

The Government says expanding bowel screening depends on increasing the availability of colonoscopies, which require ...

VANCOUVER, British Columbia -- The novel multitarget stool RNA test (ColoSense) showed high sensitivity for detecting colorectal neoplasia among adults ages 45 and older, according to the phase III ...

Stool-based screening for colorectal cancer may be sharper in women than in men, and the reason traces back to sex-specific ...

American College of Gastroenterology (ACG) gives BLUE-C study late breaker status at 2023 annual meeting with presentation of the only head-to-head study results versus FIT at ACG High specificity for ...